TIM3 and LAG3 have also found to be expressed on DLBCL cells themselves and high TIM3 expression in these tumor cells correlates with shorter survival in patients (Chen et al., 2019; Keane et al., 2020). This evidence concerns the gene HAVCR2 and diffuse large B-cell lymphoma.